Substitution of foreign protein sequences into a chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.

Por Debinski, W, Siegall, C B, Fitzgerald, D, Pastan, I
Publicado em 1991

Identification of a specific tyrosine residue in Bryodin 1 distinct from the active site but required for full catalytic and cytotoxic activity.

Por Fryxell, D. K., Gawlak, S. L., Dodge, R. W., Siegall, C. B.
Publicado em 1998

Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.

Por Siegall, C B, Chaudhary, V K, FitzGerald, D J, Pastan, I
Publicado em 1988

Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.

Por Siegall, C B, Nordan, R P, FitzGerald, D J, Pastan, I
Publicado em 1990

Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity.

Por Siegall, C B, Liggitt, D, Chace, D, Tepper, M A, Fell, H P
Publicado em 1994

Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.

Por Debinski, W, Karlsson, B, Lindholm, L, Siegall, C B, Willingham, M C, FitzGerald, D, Pastan, I
Publicado em 1992